BioCryst to Present ORLADEYO Data at ACAAI Meeting
BioCryst says it will present new ORLADEYO clinical data at the ACAAI meeting.
Related stories
Crane Reports Third-Quarter 2026 Revenue of $754.6 Million
Crane reported revenue of $754.6 million, up 28.1% year over year. Net income rose 6.5% to $97.3 million, and diluted EPS increased 6.4% to $1.66; acquisitions and core sales gains
M impact | EQUITY | Oct 29, 2026, 07:31 PM UTC
Precinct Properties announces NZ$50 million share buyback
M impact | EQUITY | Oct 29, 2026, 07:31 PM UTC
Precinct Properties New Zealand to Make NZ$103 Million Special Distribution
Precinct Properties New Zealand will make a NZ$103 million pro rata special capital distribution.
M impact | EQUITY | Oct 29, 2026, 07:31 PM UTC
US session market picture: S&P 500 -0.53%, Nasdaq 100 -1.61%; EUR/USD +0.11%, WTI -0.46%, WBD leads volume
US session market picture. US index futures: S and P futures is down 0.53 percent, Nasdaq futures is down 1.61 percent, Dow futures is down 0.47 percent and Russell futures is up 0
M impact | EQUITY | Oct 29, 2026, 07:30 PM UTC
Georgia Banking Co. Shares Trade at $40.15 After Opening at $60
Shares traded at $40.15 after opening at $60 in the company's Nasdaq debut via direct listing. Its prospectus said stockholders would sell up to 7.07 million shares.
M impact | EQUITY | Oct 29, 2026, 07:24 PM UTC
Medical Properties Trust Reports Quarterly Results
Medical Properties Trust reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 07:24 PM UTC